Acumen Ventures

The CSIRO Innovation Fund (managed by and trading as Main Sequence Ventures) is a deeptech fund, investing in companies translating research into global-scale businesses. Main Sequence Ventures knows that this takes more than money. We have our genesis in CSIRO and have access to a deep well of data scientists, physicists, synthetic biologists, chemists, astronomers and experts in other disciples. Each member of the management team has been an entrepreneur and understands the difficulties of building a company. We are here to help. We work harder to understand the world that these founders imagine. We are as comfortable in the lab as we are on the front-line with customers. We will invest capital, and ourselves, to systematically reduce risk and increase opportunity by combining the operational velocity of startups with the deep curiosity of Australia's research sector.

BMH Capital is a corporate advisory and ESG investment firm based in Sydney, Australia. Engaging with Innovative | Disruptive | Cutting-edge | Category defining businesses.

Titanium Ventures is an Australian venture capital manager investing in technology companies from Series A through growth.

CP Ventures is a boutique VC fund that invests internationally in talented passionate founders at an early stage, who are building highly scalable, future global category leading tech companies, with a high exit potential.

Rockstead is a bespoke wealth management firm focused on providing high net worth individuals, institutions and financial professionals with an all-encompassing approach to asset management and advisory strategies. Founded in 2005, Rockstead fronts value-based investment strategies and portfolio management. We offer high performing in-house hedge funds, customisable portfolio management, private equity opportunities as well as external asset management with a great team of managers dedicated to making your money work for you. The firm is a Licensed Fund Management Company (LFMC) holding a Capital Markets Services (CMS) license in fund management with the Monetary Authority of Singapore (MAS). We are also 1 of the 8 funds which qualify as a Global Investor Program fund (GIP), administered by the Economic Development Board of Singapore. In addition, Rockstead Capital is a Qualified Foreign Institutional Investor (QFII) allowing clients to make direct investments in all listed securities in China.

Wunala Capital invests in companies in the technology, financial services, healthcare and sustainable energy/transportation sectors. We focus on high-growth pre-IPO and IPO companies in Australia and offshore, notably in the USA. We have a particular expertise in supporting companies considering an IPO (or other liquidity event) within the next 12-24 months, especially those considering an ASX listing.